Financials
- Market Capitalization 2.42 B
- Employee 361
- Founded 2016
- CEO N/A
- Website www.veratx.com
- Headquarter Delaware, United States
- FIGI BBG00Q72WYG3
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1852 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 9.80 USD | -0.71% | +2.40% | +1.45% | +15.84% | 2.50 B USD | ||
| 1871 | NKTR Nektar Therapeutics - Common Stock | 71.51 USD | -4.08% | -4.03% | +0.45% | -2.40% | 2.44 B USD | ||
| 1879 | TRVI Trevi Therapeutics, Inc. - Common Stock | 16.82 USD | -6.35% | -5.98% | -8.93% | +134.59% | 2.40 B USD | ||
| 1887 | KOD Kodiak Sciences Inc - Common Stock | 37.76 USD | -3.48% | -1.92% | -6.79% | +320.02% | 2.37 B USD |
Frequently asked questions about Vera Therapeutics, Inc. Class A Common Stock
What is the Vera Therapeutics, Inc. Class A Common Stock stock price today?
The current price of Vera Therapeutics, Inc. Class A Common Stock (VERA) is 33.55. Over the past 24 hours, the stock has changed by -3.03%. Follow the VERA chart for real-time price dynamics.
What is the stock ticker of Vera Therapeutics, Inc. Class A Common Stock?
Vera Therapeutics, Inc. Class A Common Stock trades under the ticker VERA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Vera Therapeutics, Inc. Class A Common Stock stock going up?
VERA has changed by +3.26% over the last week, +1.70% over the last month, and +12.81% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Vera Therapeutics, Inc. Class A Common Stock?
Vera Therapeutics, Inc. Class A Common Stock currently has a market capitalization of 2.42 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Vera Therapeutics, Inc. Class A Common Stock earnings last quarter?
Last quarter, Vera Therapeutics, Inc. Class A Common Stock reported earnings of -1.52 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Vera Therapeutics, Inc. Class A Common Stock revenue for the last quarter?
Vera Therapeutics, Inc. Class A Common Stock reported quarterly revenue of -483 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Vera Therapeutics, Inc. Class A Common Stock net income for the last quarter?
Vera Therapeutics, Inc. Class A Common Stock reported net income of -109.47 M for the last quarter. The previous quarter showed -121.03 M, which means net income changed by +9.55%.
How many employees does Vera Therapeutics, Inc. Class A Common Stock have?
As of the latest available data, Vera Therapeutics, Inc. Class A Common Stock has 361 employees. Workforce size can provide additional context about the company's scale and operations.
What is Vera Therapeutics, Inc. Class A Common Stock EBITDA?
Vera Therapeutics, Inc. Class A Common Stock EBITDA is -112.84 M, and its EBITDA margin is 23.36 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Vera Therapeutics, Inc. Class A Common Stock stock?
You can buy Vera Therapeutics, Inc. Class A Common Stock (VERA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Vera Therapeutics, Inc. Class A Common Stock stock?
Investing in Vera Therapeutics, Inc. Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VERA chart and related analysis on metatrader.com as part of your research.